SCHEMBL21034883

SCHEMBL21034883

c1ccc2c(c1)ccc1c3cc(-c4ccc(-c5ccc6c(c5)c5ccccc5c5c7ccccc7c7ccccc7c65)c5ccccc45)ccc3oc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.44
CDC25A P30304 1/20 0.44
CDC25C P30307 1/20 0.44
CYP1A1 P04798 10/20 0.41
CYP1B1 Q16678 10/20 0.41
CYP1A2 P05177 9/20 0.40
KDM4E B2RXH2 3/20 0.40
PRKDC P78527 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
ALDH1A1 P00352 2/20 0.40
PDE5A O76074 1/20 0.40
TP53 P04637 1/20 0.40
ABCB1 P08183 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034888 0.96 ALOX5 (0.44) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL21034894 0.95 CYP1A1 (0.42) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL21034898 0.93 CYP1A1 (0.43) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL21034880 0.92 ARSA (0.44) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL21035492 0.92 CYP1A1 (0.43) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL16133277 0.92 CYP1A1 (0.43) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL21034886 0.91 CYP1A1 (0.41) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL20996055 0.90 CYP1A1 (0.43) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL21035489 0.89 CYP1A1 (0.46) CYP1A1CYP1B1CYP1A2KDM4EPRKDC
SCHEMBL21035488 0.89 CYP1A1 (0.46) CYP1A1CYP1B1CYP1A2KDM4EPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, LGR4, OR51E2 ARSA 100/4885CDC25A 4647/4885CDC25C 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.